BioWorld - Saturday, July 25, 2026 Breaking News: Single-cell transcriptome study points to new drug targets for preeclampsiaSee today's BioWorld Science Home Structural insights into small-molecule GLP-1 agonists To read the full story, subscribe or sign in
You may have a case worth reviewing if: You used Ozempic, Wegovy, Rybelsus, or another GLP-1 drug You later developed sudden vision loss, blind spots, blurred vision, or a serious optic nerve condition You were diagnosed with NAION or another serious vision-related injury Your vision problems required emergency care, specialist treatment, or ongoing follow-up You have medical records, prescription history, or ophthalmology findings linking the vision event to the period when you used the drug Your loved one suffered severe or permanent vision loss after taking one of these medications Not every eye complaint will support a lawsuit
This creates additive effects with supplement ingredients
Triiodothyronine enhances accumulation of intracellular lipids in adipocytes through thyroid hormone receptor via direct and indirect mechanisms